MedPath

Tazarotene

Generic Name
Tazarotene
Brand Names
Arazlo, Duobrii, Fabior, Tazorac
Drug Type
Small Molecule
Chemical Formula
C21H21NO2S
CAS Number
118292-40-3
Unique Ingredient Identifier
81BDR9Y8PS

Overview

Tazarotene, commonly marketed as Tazorac®, Avage®, and Zorac®, is member of the acetylenic class of retinoids. It is a prodrug that is found in topical formulations used in the treatment of various conditons, such as psoriasis, acne, and sun damaged skin (photodamage).

Background

Tazarotene, commonly marketed as Tazorac®, Avage®, and Zorac®, is member of the acetylenic class of retinoids. It is a prodrug that is found in topical formulations used in the treatment of various conditons, such as psoriasis, acne, and sun damaged skin (photodamage).

Indication

Used to treat psoriasis, acne and sun damaged skin (photodamage).

Associated Conditions

  • Psoriasis Vulgaris (Plaque Psoriasis)
  • Benign facial lentigines
  • Facial fine wrinkling
  • Facial hyperpigmentation
  • Facial hypopigmentation
  • Mild Acne vulgaris
  • Moderate Acne vulgaris

FDA Approved Products

HYALURONIC ACID SODIUM SALT 0.5% / TAZAROTENE 0.05%
Manufacturer:Sincerus Florida, LLC
Route:TOPICAL
Strength:0.05 g in 100 g
Approved: 2019/05/09
NDC:72934-2093
Tazorac
Manufacturer:Almirall, LLC
Route:CUTANEOUS
Strength:0.5 mg in 1 g
Approved: 2020/02/26
NDC:16110-833
Tazorac
Manufacturer:Almirall, LLC
Route:CUTANEOUS
Strength:1 mg in 1 g
Approved: 2020/02/26
NDC:16110-042
NIACINAMIDE 4% / TAZAROTENE 0.1%
Manufacturer:Sincerus Florida, LLC
Route:TOPICAL
Strength:0.1 g in 100 g
Approved: 2019/04/23
NDC:72934-2161
Tazarotene
Manufacturer:Pacific Pharma, Inc.
Route:TOPICAL
Strength:0.5 mg in 1 g
Approved: 2023/02/03
NDC:60758-556

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath